News | Ventricular Assist Devices (VAD) | August 11, 2016

Baseball Hall of Famer Teams With American Heart Association Against Heart Failure

Heart failure survivor partners with AHA to deliver undergarments that support and conceal the HeartMate II LVAD

Carew Medical Wear, Rod Carew, undergarments, LVAD, HeartMate II, American Heart Association

August 11, 2016 — Carew Medical Wear Inc., a custom medical outfit company specializing in left ventricular assistance device (LVAD) undergarments, has teamed up with Major League Baseball Hall of Fame inductee Rod Carew in efforts to fill the void in the garment industry that support the Heartmate II LVAD. Rod Carew, a Heart of 29 Campaigner, has teamed up with the American Heart Association to raise awareness and funds for heart disease and heart failure.  

The American Heart Association, in collaboration with the Heart Failure Society of America, recently published a report claiming more than five million Americans are living with heart failure. According to the report, there are about 600,000 new cases of heart failure recorded each year, making this patient demographic one of the largest served within the hospital setting.  

Carew suffered a massive heart attack while on a golf course in California in September 2015. After being hospitalized for more than six weeks and having several surgeries, his heart was outfitted with an LVAD. After being discharged from the hospital, Carew became increasingly concerned with his exposed LVAD. The hospital-supplied garments did little to comfortably secure either his battery pack or its hanging wires. As a result, he was inspired to address this issue.

Carew established Carew Medical Wear Inc. to fill the gap in the LVAD market, and he has since then become the company’s chief spokesperson. His hopes are to promote alternatives to device protection, specifically garments that secure all aspects of the LVAD. A medical professional within the heart failure community recently commented, “I can now send my patients skiing or biking because everything is secured and stowed away.” 

Carew Medical Wear Inc. provides heart failure patients two forms of LVAD compression undergarment protection, #29 – Left and #29 – Right. Number 29 is a reference to the number that Rod Carew wore during his tenure in the Major League Baseball uniform. Left and Right refers to which side the patient’s drive line is exiting. Each compression fitting undergarment has its own patent pending. Both of these garments accommodate and secure every single piece of the LVAD equipment including:

  • Loose cables;
  • A heat-resistant computer compartment;
  • A battery holster;
  • Drivelines; and
  • Safer transportation.

For more information: www.carewmedicalwear.com

Related Content

Novel Therapeutic Approach Effective at Reducing Pressure for Heart Failure Patients

Image courtesy of Kapur N.K., Karas R.H., Burkhoff D., et al.

News | Heart Failure | June 17, 2019
Results from a first-in-man proof of concept study found occlusion of the superior vena cava (SVC) rapidly and...
Tafamidis meglumine (Vyndaqel) is one of two new drugs cleared by the FDA for the treatment of the cardiomyopathy caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. U.S. Food and Drug Administration (FDA) approved tafamidis meglumine (Vyndaqel) and tafamidis (Vyndamax) capsules for the treatment of the cardiomyopathy.

Tafamidis meglumine (Vyndaqel) is one of two new drugs cleared by the FDA for the treatment of the cardiomyopathy caused by transthyretin mediated amyloidosis (ATTR-CM) in adults. These are the first FDA-approved treatments for ATTR-CM. 

Technology | Heart Failure | May 06, 2019
May 6, 2019 — The U.S.
The Aortic intra-aortic axial flow pump is designed to unload the heart and increase renal perfusion in heart failure patients experiencing cardiorenal syndrome.

The Aortic intra-aortic axial flow pump is designed to unload the heart and increase renal perfusion in heart failure patients experiencing cardiorenal syndrome.

Feature | Heart Failure | April 29, 2019 | Will Clifton, M.D.
The heart and kidneys are inextricably linked through a diverse web of hemodynamic, neural and hormonal mechanisms.
Diabetes Drug May Reverse Heart Failure
News | Heart Failure | April 19, 2019
Researchers at the Icahn School of Medicine at Mount Sinai have demonstrated that the recently developed antidiabetic...
Diabetes Drug Effective Against Heart Failure in Wide Spectrum of Patients
News | Heart Failure | March 29, 2019
The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are...
New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsartan (Entresto) continued to deliver reductions in the heart failure biomarker N-terminal pro–B-type natriuretic peptide (NT-proBNP), an established biomarker for heart failure severity and prognosis.[1] The data was presented as a late-breaker at the American College of Cardiology (ACC) 2019 Annual Scientific Session in March.
News | Heart Failure | March 27, 2019
March 27, 2019 —New data from a four-week extension of the landmark PIONEER-HF Trial showed the drug sacubitril/valsa
Toilet Seat Detects Congestive Heart Failure

Nicholas Conn, a postdoctoral fellow at RIT and founder and CEO of Heart Health Intelligence, is part of the university team that has developed a toilet-seat based cardiovascular monitoring system. Image courtesy of A. Sue Weisler/RIT.

News | Heart Failure | March 26, 2019
March 26, 2019 — A toilet seat-based ...
FDA Approves Optimizer Smart System for Heart Failure Patients offers cardiac contractility modulation.
Technology | Heart Failure | March 21, 2019
The U.S. Food and Drug Administration (FDA) approved Impulse Dynamics’ Optimizer Smart system for treating patients...
William T. Abraham, M.D., Joins V-Wave as Chief Medical Officer

William T. Abraham, M.D., in an interview with DAIC Editor Dave Fornell at TCT 2016.

News | Heart Failure | March 12, 2019
V-Wave Ltd. announced that renowned heart failure cardiologist William T. Abraham, M.D., is joining V-Wave as chief...
Overlay Init